We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

3 hedge funds and large institutions have $924K invested in ENDRA Life Sciences in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2,904% more capital inflows, than outflows

Capital inflows: $360K | Capital outflows: $12K

50% more funds holding

Funds holding: 2 → 3 (+1)

4.45% more ownership

Funds ownership: 3.24% → 7.69% (+4.5%)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ICM Asset Management
ICM Asset Management
Washington
+$360K

Top Sellers

Rank Fund Capital Flow
1
FNY Investment Advisers
FNY Investment Advisers
New York
-$12K

NDRA Hedge Fund Activity: Q3 2018 in Review

3 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2018, worth a combined $924K — up 186% from $323K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NDRA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was ICM Asset Management, opening a new position worth an estimated $360K. The largest seller was FNY Investment Advisers, cutting an estimated $12K.

  • 3 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2018, up from 2 in Q2 2018.
  • Funds reported $924K of ENDRA Life Sciences stock for Q3 2018, up 186% quarter-over-quarter.
  • 1 fund opened new ENDRA Life Sciences positions in Q3 2018 and 0 closed out, a net change of +1 holder.
  • The largest ENDRA Life Sciences buyer in Q3 2018 was ICM Asset Management, an estimated $360K added.
  • The largest ENDRA Life Sciences seller in Q3 2018 was FNY Investment Advisers, an estimated $12K sold.

Based on aggregated 13F filings for Q3 2018.